期刊文献+

武汉市大学生精神疾病临床调查及预防干预 被引量:3

Clinic Survey and Prevention Intervention for College Students with Mental Disorders,Wuhan
下载PDF
导出
摘要 目的:调查武汉大学生精神疾病患者,为高校精神疾病预防干预提供科学依据。方法:对197例大学生精神疾病患者住院记录进行档案研究,并对其中15名住院患者进行深度访谈。结果:武汉大学生精神疾病高发年龄是20-21岁,男性多于女性;精神疾病类型以情感类障碍为主,抑郁症和精神分裂症最为常见;平均病程为65天。大学生精神疾病是多种因素迭加产生的结果,深度访谈从生理、社会、心理、应激、适应功能和风险性6个方面描述了大学生精神疾病的高危特征。结论:高校应重视精神卫生服务,整合个体与社区水平形成系统的预防干预。 Objective: The paper aimed at providing evidence for college crisis intervention through clinic investigations. Methods: 197 hospital records of college students with mental disorders in Wuhan were used in document research, and 15 patients among them were invited to interview one-to-one. Results: There are three distinguishing features among those clients: the age of onset was 20-21 at most, men's incident rate were more than women's; emotional disorders were most popular among college students, and depress disorder and schizophrenia were at the top of disorders; average of courses were 65 days. According to interview research, multiple factors resulted in college students of mental disorders, which high risk traits are described at six dimensionality including physiological, social, psychological, stress, school adjustment and risk factors. Conclusion: Scientific and systemic preventive intervention programs are recommended to develop in all colleges, and individual-level interventions should be integrated with community-level interventions basing on local characteristics.
出处 《医学与社会》 2012年第9期75-78,共4页 Medicine and Society
基金 湖北省人文社科项目 编号为2008z017
关键词 精神疾病 预防干预 大学生 Mental disorders Preventive intervention College students
  • 相关文献

参考文献13

二级参考文献33

共引文献564

同被引文献34

  • 1傅伟忠.4007名大中学生心理卫生知识知晓率的现状调查[J].上海精神医学,2005,17(B09):12-13. 被引量:24
  • 2EMSLEY R, OOSTHUIZEN P, KOEN L, et al. Remission in patients with first-episode schizophrenia receiving assured antipsychotic medication: a study with risperidone longacting injection [J]. Int Clin Psychopharmacol, 2008 , 23 (6): 325-331. 被引量:1
  • 3NUSSBAUM AM, STROUP T S. Paliperidone palmitate for schizophrenia [J]. Cochrane Library ,2012,3 (6) :69-72. 被引量:1
  • 4LIEBERMAN J A, STROUP T S, MCEUOY J P, et al. Eff- ectiveness of antipsychotic drugs in patients with chronic schizophrenia [J]. N Engl J Med, 2005 , 353 ( 12) : 1209 - 1223. 被引量:1
  • 5MCEVOY J P, LIEBERMAN J A, PERKINS D 0, et al. Efficacy and tolerability of olanzapine , quetiapine, and risperidone in the treatment of early psychosis: a randomized, double-blind 52-week comparison [J]. Am J Psychiatry ,2007,164(7) : 1050-1060. 被引量:1
  • 6SABATE E. Adherence to long-term therapies: evidence for action [Z]. Geneva, Switzerland: W orId Health Organization, 2003. 被引量:1
  • 7NEWTON R,HUSTIG H,LAKSHMANA R,et al. Practical guidelines on the use of paliperidone palmitate in schizophrenia[J] . CUff Med Res Opin , 2012,28 ( 4) : 559- 567. 被引量:1
  • 8CHUE P, CHUE J. A review of paliperidone palmitate [J] . Expert Rev. Neurother,2012,12(12) :1383-1397. 被引量:1
  • 9PEUSKENS J, RUBIO G, SCHREINER A. Dosing and switching of paliperidone ER in patients with schizophrenia: recommendations for clinical practice [J]. Ann Gen Psychiatry ,2014,13 (1) : 10. 被引量:1
  • 10LEUCHT C,HERES S,KANE J M,et al. Oral versus depot antipsychotic dTIlgs for schizophrenia-a critical systematic review and meta-analysis of randomised long-term trials[J]. Schizophr Res,2011 ,127( 1-3) :83-92. 被引量:1

引证文献3

二级引证文献28

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部